Sichuan Kelun Pharmaceutical Co Ltd (002422) - Total Assets

Latest as of March 2026: CN¥41.14 Billion CNY ≈ $6.02 Billion USD

Based on the latest financial reports, Sichuan Kelun Pharmaceutical Co Ltd (002422) holds total assets worth CN¥41.14 Billion CNY (≈ $6.02 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Sichuan Kelun Pharmaceutical Co Ltd - Total Assets Trend (2007–2025)

This chart illustrates how Sichuan Kelun Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see market value of Sichuan Kelun Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Sichuan Kelun Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Sichuan Kelun Pharmaceutical Co Ltd's total assets of CN¥41.14 Billion consist of 50.3% current assets and 49.7% non-current assets. Review debt load of Sichuan Kelun Pharmaceutical Co Ltd to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	15.1%
Accounts Receivable	CN¥4.67 Billion	11.7%
Inventory	CN¥3.85 Billion	9.7%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥1.23 Billion	3.1%
Goodwill	CN¥96.25 Million	0.2%

Asset Composition Trend (2007–2025)

This chart illustrates how Sichuan Kelun Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Sichuan Kelun Pharmaceutical Co Ltd (002422) share price today for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Sichuan Kelun Pharmaceutical Co Ltd's current assets represent 50.3% of total assets in 2025, a decrease from 61.8% in 2007.
Cash Position: Cash and equivalents constituted 15.1% of total assets in 2025, up from 5.8% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 4.0% in 2007.
Asset Diversification: The largest asset category is accounts receivable at 11.7% of total assets.

Sichuan Kelun Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Sichuan Kelun Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Novartis AG SW:NOVN	Switzerland	CHF118.89 Billion
AstraZeneca PLC LSE:AZN	UK	GBX116.43 Billion
Pfizer Inc SA:PFIZ34	Brazil	R$201.13 Billion
AbbVie Inc NYSE:ABBV	USA	$136.46 Billion
Merck & Company Inc NYSE:MRK	USA	$129.80 Billion
AstraZeneca PLC F:ZEGA	Germany	€114.46 Billion
Pfizer Inc NYSE:PFE	USA	$201.13 Billion
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	China	CN¥2.29 Billion

Sichuan Kelun Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.11	2.03	1.10
Quick Ratio	1.74	1.61	0.85
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥11.22 Billion	CN¥9.40 Billion	CN¥1.31 Billion

Sichuan Kelun Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Sichuan Kelun Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.00
Latest Market Cap to Assets Ratio	0.24
Asset Growth Rate (YoY)	6.7%
Total Assets	CN¥39.83 Billion
Market Capitalization	$9.67 Billion USD

Valuation Analysis

Below Book Valuation: The market values Sichuan Kelun Pharmaceutical Co Ltd's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Sichuan Kelun Pharmaceutical Co Ltd's assets grew by 6.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual total assets of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥39.83 Billion ≈ $5.83 Billion	+6.75%
2024-12-31	CN¥37.32 Billion ≈ $5.46 Billion	+2.36%
2023-12-31	CN¥36.45 Billion ≈ $5.33 Billion	+6.57%
2022-12-31	CN¥34.21 Billion ≈ $5.01 Billion	+8.45%
2021-12-31	CN¥31.54 Billion ≈ $4.62 Billion	-1.47%
2020-12-31	CN¥32.01 Billion ≈ $4.68 Billion	+1.67%
2019-12-31	CN¥31.49 Billion ≈ $4.61 Billion	+7.30%
2018-12-31	CN¥29.34 Billion ≈ $4.29 Billion	+4.85%
2017-12-31	CN¥27.99 Billion ≈ $4.10 Billion	+19.56%
2016-12-31	CN¥23.41 Billion ≈ $3.43 Billion	+3.66%
2015-12-31	CN¥22.58 Billion ≈ $3.30 Billion	+6.51%
2014-12-31	CN¥21.20 Billion ≈ $3.10 Billion	+18.14%
2013-12-31	CN¥17.95 Billion ≈ $2.63 Billion	+20.20%
2012-12-31	CN¥14.93 Billion ≈ $2.18 Billion	+42.67%
2011-12-31	CN¥10.47 Billion ≈ $1.53 Billion	+18.63%
2010-12-31	CN¥8.82 Billion ≈ $1.29 Billion	+164.65%
2009-12-31	CN¥3.33 Billion ≈ $487.78 Million	+25.50%
2008-12-31	CN¥2.66 Billion ≈ $388.68 Million	+48.62%
2007-12-31	CN¥1.79 Billion ≈ $261.53 Million	--

About Sichuan Kelun Pharmaceutical Co Ltd

SHE:002422 China Drug Manufacturers - General

Market Cap

$9.67 Billion

CN¥66.08 Billion CNY

Market Cap Rank

#2308 Global

#248 in China

Share Price

CN¥41.54

Change (1 day)

-0.91%

52-Week Range

CN¥28.83 - CN¥51.35

All Time High

CN¥51.35